share_log

中國抗體-B:自願公告 SM17在中國I期臨床試驗完成首個隊列的健康受試者給藥

SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT FIRST COHORT OF THE HEALTHY SUBJECTS DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN CHINA

香港交易所 ·  Nov 27, 2023 08:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more